Inclusive of all taxes
1 Prefilled Syringe(s)
Darbelife 40mcg Injection (PFS) contains Darbepoetin alfa, a medicine from the class of erythropoiesis stimulating agents. It is used to treat symptomatic anemia caused by chronic kidney disease (CKD) in both adults and children. In CKD, kidneys produce less erythropoietin a hormone needed to make red blood cells leading to anemia.
Before starting treatment, your doctor will likely perform blood tests to monitor your response and may adjust your dose accordingly. Blood pressure will also be closely monitored, especially during the early stages of treatment.
This injection is not recommended for patients with uncontrolled high blood pressure. Inform your doctor if you have a history of controlled hypertension, sickle cell anemia, seizures, liver disease, poor response to previous anemia treatments, latex allergy, or hepatitis C.
Use of Darbelife 40mcg Injection should be done with caution in pregnant women, and breastfeeding is not advised during treatment. It is not recommended for infants under 1 month old with CKD. Its safety and effectiveness in children with cancer have not been established, so always consult a pediatrician for guidance.
Common side effects may include increased blood pressure, allergic reactions, pain at the injection site, skin rash, or redness. Contact your doctor if any side effects become severe or persistent.
Darbelife 40mcg Injection is used to treat symptomatic anemia (low red blood cell count) in patients with chronic renal failure, including those on dialysis and those not on dialysis. It helps stimulate the bone marrow to produce more red blood cells by mimicking the action of erythropoietin, a natural hormone usually produced by healthy kidneys.
It is also indicated for use in children with CKD who are experiencing anemia, helping to reduce symptoms such as fatigue, weakness, and shortness of breath.
Darbelife40mcg Injection contains Darbepoetin alfa, a synthetic form of erythropoietin, a hormone naturally produced by the kidneys. It works by stimulating the bone marrow to produce more red blood cells.
In patients with chronic kidney disease (CKD), the kidneys fail to produce enough erythropoietin, leading to anemia. Darbepoetin alfa binds to the erythropoietin receptors on bone marrow cells, activating them to increase red blood cell production. This helps improve oxygen delivery throughout the body and relieves symptoms of anemia such as tiredness and weakness.
Side Effects of Darbelife 40mcg Injection
Serious Side Effects (Seek immediate medical attention):
Common Side Effects (Usually mild and temporary):
The dosage of Darbelife 40mcg Injection (Darbepoetin alfa) depends on the patient's body weight, the severity of anemia, and whether the patient is on dialysis or not. It is usually administered under the supervision of a healthcare professional.
Note: Darbelife Injection should always be used exactly as prescribed. Never self administer or change the dose without consulting your doctor.
Do not breastfeed while receiving Darbelife, as it is not known if the medicine passes into breast milk and may affect your baby.
There is no known interaction with alcohol, but it’s best to consult your doctor before consuming alcohol while using this medicine.
Darbelife Injection may rarely cause breathing issues or lung problems. Seek medical help if you develop chest pain, cough, or shortness of breath, and inform your doctor about any existing lung conditions.
Darbelife is not likely to affect your ability to drive or use machines. However, if you feel dizzy, tired, or unwell, avoid driving until you feel better.
Darbelife should be used during pregnancy only if clearly needed. Talk to your doctor about the risks and benefits before starting this medication.
Darbelife 40 mcg Injection is used to treat anemia caused by chronic kidney disease (CKD) in both adults and children. It helps your body make more red blood cells.
It contains Darbepoetin alfa, which acts like a natural hormone called erythropoietin. It stimulates the bone marrow to produce red blood cells, helping to improve symptoms like tiredness and weakness.
It is given either under the skin (subcutaneous) or into a vein (intravenous), usually by a doctor or nurse at a hospital or clinic.
The frequency depends on your condition. It is usually given once a week, every two weeks, or even every four weeks, based on your response and whether you are on dialysis.
In some cases, your doctor may train you or a caregiver to give the injection at home. Always follow medical guidance carefully if doing so.
Common side effects include high blood pressure, injection site pain, rash, and flu-like symptoms. Serious side effects like seizures or allergic reactions are rare but require immediate medical attention.
Darbelife should be used in pregnancy only if advised by your doctor. Do not breastfeed while using this medicine.
Yes, it can be used in children with anemia caused by kidney disease, but not in infants under 1 month of age. Safety in children with cancer has not been established.
If you miss a dose, inform your doctor as soon as possible. Do not double the dose to make up for the missed one.
No. Do not stop the treatment without consulting your doctor, even if you feel better. Stopping it suddenly may cause your anemia to return.
| Active ingredient | Darbepoetin alfa |
| Pharmacologic class | Erythropoiesis-Stimulating Agent (ESA) |
| Medication category | Hematopoietic Agent |
| Dosage forms | Injection |
Azadine 100mg Injection contains Azacitidine which belongs to the group of medicines called Anticancer agents. It is used in adults to treat all sub-types of myelodysplastic syndromes (MDS; group of cancers associated with blood and bone marrow) and certain types of blood cancers known as Chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).
Azadine 100mg Injection is typically used in adults who cannot undergo stem cell transplantation. It may be also used to treat other conditions, as determined by the doctor.
Azadine Injection is given as an injection under the medical supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised.
You must inform your doctor before taking any vaccination while on treatment with this medicine. Regular blood tests are required to check your blood cells along with the heart, liver, and kidney.
Before taking it, tell your doctor if you have liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using.
Azadine 100mg Injection is an anticancer medication. It works by blocking the actions of certain enzymes (DNA/RNA methyltransferase) within the cancer cells that is required for the cells to grow and multiply. It also reduces the production of new genetic material (RNA and DNA) within the cells. As a result, it prevents abnormal cell division within the body, slows down the growth of cancer cells and helps the bone marrow to produce normal blood cells.
It is used to treat:
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Ques 1: What is the use of AZADINE 100MG INJECTION?
Ans :AZADINE 100MG INJECTION is used in adults to treat all sub-types of myelodysplastic syndromes (MDS; group of cancers associated with blood and bone marrow) and certain types of blood cancers known as Chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia (AML).
Ques 2: How does AZADINE 100MG INJECTION works?
Ans :AZADINE 100MG INJECTION is an anticancer medication. It works by blocking the actions of certain enzymes (DNA/RNA methyltransferase) within the cancer cells that is required for the cells to grow and multiply. It also reduces the production of new genetic material (RNA and DNA) within the cells. As a result, it prevents abnormal cell division within the body, slows down the growth of cancer cells and helps the bone marrow to produce normal blood cells.
Ques 3: Can I take AZADINE 100MG INJECTION during breastfeeding?
Ans :No. AZADINE 100MG INJECTION is not recommended for use in breast-feeding women. Therefore, inform your doctor before receiving it.
Ques 4: Can AZADINE 100MG INJECTION increase the risk of infections?
Ans :AZADINE 100MG INJECTION may cause a drop in the number of white blood cells in the body and may weaken your immune system. As a result, you may be at a greater risk of getting infected while receiving AZADINE 100MG INJECTION. To avoid this, your doctor will regular monitor your blood counts as a precaution. However, inform your doctor if you experience any signs of infection such as fever.
Ques 5: Can the use of AZADINE 100MG INJECTION make me feel tired?
Ans :Yes. AZADINE 100MG INJECTION may make you feel tired easily. This is because, it reduces the levels of red blood cells in your blood and may make you anemic. Consult your doctor if you experience tiredness after receiving AZADINE 100MG INJECTION. Tiredness can also occur if you have any pre-existing disease conditions such as liver or kidney impairment while receiving this medicine.
Ques 6: Can I drive a car after receiving AZADINE 100MG INJECTION?
Ans :AZADINE 100MG INJECTION may make you feel tired or weak. Therefore, do not drive or operate any heavy tools or machines if your ability is affected by AZADINE 100MG INJECTION.
Ques 7: How AZADINE 100MG INJECTION is administered?
Ans :AZADINE 100MG INJECTION will be given to you only by a doctor or a nurse beneath the skin (subcutaneously) of thighs, arms or abdomen.
Ques 8: How to control nausea caused due to AZADINE 100MG INJECTION?
Ans :Generally, anticancer medicines are associated with uncontrollable nausea and vomiting. To avoid this, your doctor would prescribe a suitable medicine to control them along with AZADINE 100MG INJECTION. If not, consult your doctor for a suitable anti-emetic medicine. Do not self-treat nausea.
Darbelife 40mcg Injection (PFS) contains Darbepoetin alfa, a medicine from the class of erythropoiesis stimulating agents. It is used to treat symptomatic anemia caused by chronic kidney disease (CKD) in both adults and children. In CKD, kidneys produce less erythropoietin a hormone needed to make red blood cells leading to anemia.
Before starting treatment, your doctor will likely perform blood tests to monitor your response and may adjust your dose accordingly. Blood pressure will also be closely monitored, especially during the early stages of treatment.
This injection is not recommended for patients with uncontrolled high blood pressure. Inform your doctor if you have a history of controlled hypertension, sickle cell anemia, seizures, liver disease, poor response to previous anemia treatments, latex allergy, or hepatitis C.
Use of Darbelife 40mcg Injection should be done with caution in pregnant women, and breastfeeding is not advised during treatment. It is not recommended for infants under 1 month old with CKD. Its safety and effectiveness in children with cancer have not been established, so always consult a pediatrician for guidance.
Common side effects may include increased blood pressure, allergic reactions, pain at the injection site, skin rash, or redness. Contact your doctor if any side effects become severe or persistent.
Darbelife 40mcg Injection is used to treat symptomatic anemia (low red blood cell count) in patients with chronic renal failure, including those on dialysis and those not on dialysis. It helps stimulate the bone marrow to produce more red blood cells by mimicking the action of erythropoietin, a natural hormone usually produced by healthy kidneys.
It is also indicated for use in children with CKD who are experiencing anemia, helping to reduce symptoms such as fatigue, weakness, and shortness of breath.
Darbelife40mcg Injection contains Darbepoetin alfa, a synthetic form of erythropoietin, a hormone naturally produced by the kidneys. It works by stimulating the bone marrow to produce more red blood cells.
In patients with chronic kidney disease (CKD), the kidneys fail to produce enough erythropoietin, leading to anemia. Darbepoetin alfa binds to the erythropoietin receptors on bone marrow cells, activating them to increase red blood cell production. This helps improve oxygen delivery throughout the body and relieves symptoms of anemia such as tiredness and weakness.
Side Effects of Darbelife 40mcg Injection
Serious Side Effects (Seek immediate medical attention):
Common Side Effects (Usually mild and temporary):
The dosage of Darbelife 40mcg Injection (Darbepoetin alfa) depends on the patient's body weight, the severity of anemia, and whether the patient is on dialysis or not. It is usually administered under the supervision of a healthcare professional.
Note: Darbelife Injection should always be used exactly as prescribed. Never self administer or change the dose without consulting your doctor.
Do not breastfeed while receiving Darbelife, as it is not known if the medicine passes into breast milk and may affect your baby.
There is no known interaction with alcohol, but it’s best to consult your doctor before consuming alcohol while using this medicine.
Darbelife Injection may rarely cause breathing issues or lung problems. Seek medical help if you develop chest pain, cough, or shortness of breath, and inform your doctor about any existing lung conditions.
Darbelife is not likely to affect your ability to drive or use machines. However, if you feel dizzy, tired, or unwell, avoid driving until you feel better.
Darbelife should be used during pregnancy only if clearly needed. Talk to your doctor about the risks and benefits before starting this medication.
Darbelife 40 mcg Injection is used to treat anemia caused by chronic kidney disease (CKD) in both adults and children. It helps your body make more red blood cells.
It contains Darbepoetin alfa, which acts like a natural hormone called erythropoietin. It stimulates the bone marrow to produce red blood cells, helping to improve symptoms like tiredness and weakness.
It is given either under the skin (subcutaneous) or into a vein (intravenous), usually by a doctor or nurse at a hospital or clinic.
The frequency depends on your condition. It is usually given once a week, every two weeks, or even every four weeks, based on your response and whether you are on dialysis.
In some cases, your doctor may train you or a caregiver to give the injection at home. Always follow medical guidance carefully if doing so.
Common side effects include high blood pressure, injection site pain, rash, and flu-like symptoms. Serious side effects like seizures or allergic reactions are rare but require immediate medical attention.
Darbelife should be used in pregnancy only if advised by your doctor. Do not breastfeed while using this medicine.
Yes, it can be used in children with anemia caused by kidney disease, but not in infants under 1 month of age. Safety in children with cancer has not been established.
If you miss a dose, inform your doctor as soon as possible. Do not double the dose to make up for the missed one.
No. Do not stop the treatment without consulting your doctor, even if you feel better. Stopping it suddenly may cause your anemia to return.
| Active ingredient | Darbepoetin alfa |
| Pharmacologic class | Erythropoiesis-Stimulating Agent (ESA) |
| Medication category | Hematopoietic Agent |
| Dosage forms | Injection |
Life-Saving Medicines Expert
Affordable Patient-Centered Care
Authentic, Top-Quality Medicines
Careful & Timely Medicine Deliveries
Login with Facebook
Login with Google
